Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.
作者信息
Sánchez-Castro Grimelda Yuriana, Hitos-Fájer Alejandra, Mendoza-Schuster Erick, Velez-Montoya Raul, Velasco-Barona Cecilio Francisco
机构信息
Asociación para Evitar la Ceguera en México. Hospital "Dr. Luis Sánchez Bulnes", México, D.F. Ophthalmology Department - Anterior Segment, Mexico.
出版信息
Clin Ophthalmol. 2008 Sep;2(3):657-60. doi: 10.2147/opth.s2686.
Abstract
We reported a 75-year-old diabetic man, who developed opacification and neovascularization of the posterior capsule after extracapsular cataract extraction and posterior chamber intraocular lens implantation. The patient was treated with two injections of 2.5 mg of intravitreal bevacizumab. The treatment produced an important regression of the posterior capsular new vessels, allowing us to perform a successful Nd:YAG capsulotomy, clearing the visual axis and improving the visualization of the posterior pole. Even though, best corrected visual acuity was 20/200 due to diabetic macular edema.
摘要
相似文献
1
Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.
Clin Ophthalmol. 2008 Sep;2(3):657-60. doi: 10.2147/opth.s2686.
2
Results of Nd:YAG laser capsulotomy in posterior capsule opacification.
Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):357-63.
3
Reopacification of posterior capsular opening after ND: YAG capsulotomy: 2 cases with the different presentation.
Rom J Ophthalmol. 2019 Oct-Dec;63(4):387-390.
4
Refraction, intraocular pressure and anterior chamber depth changes after Nd:YAG laser treatment for posterior capsular opacification in pseudophakic eyes.
Clin Exp Optom. 2009 Sep;92(5):412-5. doi: 10.1111/j.1444-0938.2009.00401.x. Epub 2009 Jun 22.
5
The madurai intraocular lens study IV: posterior capsule opacification.
Am J Ophthalmol. 2000 Sep;130(3):304-9. doi: 10.1016/s0002-9394(00)00481-5.
6
Incidence of posterior capsular opacification requiring Nd:YAG capsulotomy after cataract surgery and implantation of enVista MX60 IOL.
J Fr Ophtalmol. 2018 Dec;41(10):899-903. doi: 10.1016/j.jfo.2018.04.011. Epub 2018 Nov 23.
7
Accommodation after Nd: YAG capsulotomy in patients with accommodative posterior chamber lens 1CU.
Graefes Arch Clin Exp Ophthalmol. 2005 Feb;243(2):120-6. doi: 10.1007/s00417-004-1041-5. Epub 2004 Dec 14.
8
9
Effect of Nd:YAG Laser Capsulotomy on Anterior Segment Parameters in Patients with Posterior Capsular Opacification after Phacovitrectomy.
Korean J Ophthalmol. 2018 Oct;32(5):369-375. doi: 10.3341/kjo.2018.0020.
10
Late capsular block syndrome presenting with posterior capsule opacification.
J Cataract Refract Surg. 2012 Apr;38(4):672-6. doi: 10.1016/j.jcrs.2011.11.024. Epub 2012 Feb 10.
引用本文的文献
1
Posterior Capsule Opacification: A Review of Experimental Studies.
J Clin Med. 2021 Jun 27;10(13):2847. doi: 10.3390/jcm10132847.
2
Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.
Am J Ophthalmol Case Rep. 2020 Oct 3;20:100943. doi: 10.1016/j.ajoc.2020.100943. eCollection 2020 Dec.
3
Clinical Ophthalmology and PubMed.
Clin Ophthalmol. 2008 Sep;2(3):i.
本文引用的文献
1
Photodynamic therapy for posterior capsule neovascularization.
J Cataract Refract Surg. 2007 Jun;33(6):1131-2. doi: 10.1016/j.jcrs.2007.02.025.
2
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.
J Cataract Refract Surg. 2007 Jun;33(6):1113-5. doi: 10.1016/j.jcrs.2007.01.040.
3
Pharmacokinetics of intravitreal bevacizumab (Avastin).
Ophthalmology. 2007 May;114(5):855-9. doi: 10.1016/j.ophtha.2007.01.017.
4
The management of diabetic eye disease in the setting of cataract surgery.
Curr Opin Ophthalmol. 2007 Feb;18(1):13-8. doi: 10.1097/ICU.0b013e32801129fc.
5
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Ophthalmology. 2006 Oct;113(10):1695.e1-15. doi: 10.1016/j.ophtha.2006.05.064.
6
Posterior capsule opacification after cataract surgery in patients with diabetes mellitus.
J Cataract Refract Surg. 2006 Jul;32(7):1184-7. doi: 10.1016/j.jcrs.2006.01.100.
7
Cataract surgery and postoperative complications in diabetic patients.
Coll Antropol. 2005;29 Suppl 1:55-8.
8
Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery.
J Cataract Refract Surg. 2004 Feb;30(2):428-32. doi: 10.1016/S0886-3350(03)00579-0.
9
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
N Engl J Med. 2003 Jul 31;349(5):427-34. doi: 10.1056/NEJMoa021491.
10
Posterior capsule opacification after cataract surgery in patients with diabetes mellitus.
Am J Ophthalmol. 2002 Jul;134(1):10-6. doi: 10.1016/s0002-9394(02)01461-7.
Zotero 插件